A/Professor Mihir Gandhi

Chan Shih-Yen

PhD, CStat, CSci
Head of Biostatistics, SCRI
Assistant Professor, Duke-NUS Medical School
Visiting Researcher, Global Health Group, Center for Child Health Research, Tampere University, Finland 

Mihir Gandhi is a medical statistician and Head of Biostatistics, SCRI. He is also affiliated with Duke-NUS Medical School, Singapore as an Assistant Professor and the Global Health Group at the Center for Child Health Research, Tampere University, Finland as a Visiting Researcher.

He received his Bachelor and Master’s degree with the first rank gold medal in Statistics from the M. S. University of Baroda, India and a PhD degree from the Tampere University, Finland. He has worked as a biostatistician in leading multinational pharmaceutical companies and clinical research organizations in India and Singapore.

He is primarily working on planning, analysis and reporting of clinical trials. He has experience in wide range of therapeutic areas such as oncology, paediatrics, and hypertension. He has also worked on medical device and health services research studies. In addition to clinical trials, he has research interest in applied statistics, health-related quality of life and health state valuation.

Research Interests

  • Health-related quality of life measurement, Health services research, Oncology, Child growth and development, Applied medical statistics


Selected Publications:

  1. Gandhi M, Ashorn P, Maleta K, Teivaanmäki T, Duan X, Cheung YB. Height gain during early childhood is an important predictor of schooling and mathematics ability outcomes. Acta Paediatrica. Aug 2011; 100(8): 1113-1118.

  2. Gandhi M, Mukherjee B, Biswas D. A Bayesian approach for inference from a bridging study with binary outcomes. Journal of Biopharmaceutical Statistics. Sep 2012; 22(5):935-51.

  3. Gandhi M, Teivaanmäki T, Maleta K, Duan X, Ashorn P, Cheung YB. Child development at 5 years of age predicted mathematics ability and schooling outcomes in Malawian adolescents. Acta Paediatrica. Jan 2013; 102(1); 58-65.

  4. Aris IM, Gandhi M, Cheung YB, Soh SE, Tint MT, Gluckman PD, Lee YS, Yap FK, Yap SC. A new population-based reference fro gestational age-specific size-at-birth of Singapore infants. Annals of the Academy of Medicine Singapore. Sep 2014; 43(9): 439-447.

  5. Gandhi M, Thumboo J, Nuo L, Wee HL, Cheung YB. Do chronic disease patients value generic health states differently from individuals with no chronic disease? A case of a multicultural Asian population.  Health and Quality of Life Outcomes. Jan 2015; 13: 8.

  6. Gandhi M, Tan SB, Chung AYF, Machin D. On developing a pragmatic strategy for clinical trials: A case study of hepatocellular carcinoma. Contemporary clinical trials. Jul 2015; 43: 252-259.

  7. Phillips R, Gandhi M, Cheung YB, Findlay MP, Wi KM, Hong HH, Yang J, Lobo RR, Soo KC, Chow PK. Summary scores captured changes in subjects’ QoL as measured by the multiple scales of the EORTC QLQ-C30. Journal of Clinical Epidemiology. Aug 2015; 68(8):895-902.

  8. Gandhi M, Thumboo J, Wee HL, Luo N, Cheung YB. How the most severe health state being valued by the general population? Health and Quality of Life Outcomes. Oct 2014; 12: 161.

  9. Gandhi M, Xu Y, Luo N, Cheung YB. Sample size determination for EQ-5D-5L value set studies. Quality of Life Research. Dec 2017; 26(12): 3365-3376.

  10. Gandhi M, Tan RS, Ng R, Choo SP, Chia WK, Toh CK, Lam C, Lee PT, Latt NKZ, Rand-Hendriksen K, Cheung YB, Luo N. Comparison of health state values derived from patients and individuals from the general population. Quality of Life Research. Dec 2017; 26(12): 3353-3363.

  11. Chow PKH, Gandhi M, Tan SB,  et al. SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma. Journal of Clinical Oncology. Jul 2018; 36(19): 1913-1921.

  12. Jafar TH, Gandhi M, Jehan I, Naheed A, de Silva HA, Shahab H, Alam D, Luke N, Lim CW; COBRA-BPS Study Group. Determinants of Uncontrolled Hypertension in Rural Communities in South Asia – Bangladesh, Pakistan, and Sri Lanka. American Journal of Hypertension. Oct 2018; 31(11): 1205-1214.

  13. Gandhi M, Ang M, Teo K, Wong CW, Wei YC, Tan RL, Janssen MF, Luo N. EQ-5D-5L is more responsive than EQ-5D-3L to treatment benefit of cataract surgery. The Patient – Patient-Centered Outcomes Research. Jan 2019; Epub.

  14. Gandhi M, Rand K, Luo N. Valuation of health states considered to be worse than death – An analysis of composite time trade-off data from five EQ-5D-5L valuation studies. Value in Health. March 2019; 22(3): 370-376.

  15. Gandhi M, Ang M, Teo K, Wong CW, Wei YC, Tan RL, Janssen MF, Luo N. A vision ‘bolt-on’ increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery. European Journal of Health Economics. Jan2020: Epub.


Google Scholar Publications